Stockreport

Genmab (GMAB) Reports 19% Revenue Growth to $3.7B in 2025 Driven by Proprietary Medicine Sales [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Genmab (GMAB) Reports 19% Revenue Growth to $3.7B in 2025 Driven by Proprietary Medicine Sales [Read more]